The article features the successful evaluation by the Leicester Royal Infirmary of Amplidiag® Easy, the automated solution for routine diagnostic screening by Mobidiag.Read Full Article
In the scope of the World Antibiotic Awareness Week 2018, Bpifrance (French Public Investment Bank) has highlighted the French key players in the field of antibiotic resistance.
The World Week for the Proper Use of Antibiotics (November 12-18, 2018) organized following the appeal of international institutions such as the World Health Organization (WHO), is an opportunity for Bpifrance to make a inventory of antimicrobial resistance in France.
We are very proud to see Mobidiag being recognized as a key player in the fight against antibiotic resistance in France. For more information, please read the full article.
The article presents the results of the multicentric prospective study carried out in the framework of the Hepystool Hospital Clinical Research Project on 1,200 patients.
In this article, Professor Christophe BURUCOA, PUPH, Head of Laboratory Bacteriology and Hygiene Department, Poitiers Hospital, presents the results of the multicentric prospective study carried out in the framework of the Hepystool Hospital Clinical Research Project.
The purpose of this study was to establish a direct comparison between a non-invasive molecular diagnostics test for the detection of the Helicobacter pylori bacteria and its resistance to clarithromycin from stools, and classical methods with culture and PCR on biopsy. They have then evaluated the multiplex qPCR test Amplidiag® H. pylori+ClariR<
The article focuses on Novodiag® solution, the automated molecular diagnostic system allowing rapid and reliable results directly from patient sample.
Our CEO Tuomas Tenkanen explains Mobidiag’s positioning and its dedication to the fight against antibiotic resistances.
Learn more about Mobidiag and our everyday mission in supporting diagnostics of infectious diseases (“Portrait d’entreprise” broadcasted on French TV channel LCI – La Chaine Info: